Next Generation Core Industrial Ecosystem (NXCIS)
The page lists key research disciplines influencing the future of health.
bico.comCrawled Nov 17, 2026
The page lists key research disciplines influencing the future of health.
BICO’s technologies accelerate workflows in drug discovery and tissue engineering, supporting high-throughput, reproducible research across life sciences.
Genomics and transcriptomics analyze DNA and RNA to advance biology, medicine, and drug development using techniques like NGS and RNA sequencing.
The page discusses replacing animal studies with printed tissues as a more ethical, precise, and cost-effective research model.
Personalized medicine tailors therapies to individual patients using genetics, molecular biology, and patient-specific data for improved outcomes.
BICO’s products combine instruments, software, consumables, and services to help life-science labs generate predictive, reproducible biological data.
BICO appointed Åsa Hillsten as SVP and Head of Investor Relations to improve market communication and clarify its business model.
BICO joined the NA3RsC MPS Initiative to promote industry adoption of microphysiological technologies and reduce animal testing.
BICO’s subsidiary Biosero received a patent for a laboratory automation approach that increases productivity and efficiency.
The page describes how researchers use BICO products to advance scientific discovery.
Ronawk mass-produces adult stem cells using bioprinters from CELLINK paving the way for the possibility to grow and transplant patients' own stem cells without the need for the immunosuppressive drugs that are usually required after an organ donation.
Carcinotech bioprints patient-specific test models with cells from biopsy samples and has benefited greatly from CELLINK's expertise in the field.
BICO acquired Allegro 3D for $11 million, including a $5 million earn-out contingent on performance.
BICO acquired Biosero, a company offering laboratory automation solutions under the Green Button Go brand.
BICO’s Bioautomation division introduced The Nucleus Automation Ecosystem, integrating ABB Robotics for scalable manufacturing.
The page lists the latest news from BICO’s business areas.
The page provides regulatory and non-regulatory press releases from BICO Group AB.
BICO enables and automates the life science lab of the future.
BICO develops precision technologies for life science labs to accelerate discoveries that improve lives.
BICO integrates sustainability into its HR strategy to support employee well-being.
View all insider positions and insider transactions of BICO Group AB.
Lars, a former CFO with 25 years of experience, joined BICO as Senior Financial Controller to improve financial reporting and integration.
View all Board of directors at BICO Group AB.
View the composition of the Nomination Committee of BICO Group AB.
Biosero’s Acceleration Lab provides custom demonstrations, virtual tours, and product testing for laboratory automation solutions.
BICO aims to replace animal testing in drug discovery and cosmetic testing.
BICO’s 2030 strategy focuses on Precision Biology to drive sustainable growth in life-science laboratories.
BICO enables life science labs to accelerate discoveries through precision biology and reproducible results.
BICO’s sustainability agenda aligns operations with UN Sustainable Development Goals through bioconvergence.
BICO creates the future of life-saving treatments by reducing organ shortages and accelerating drug development.
Bioconvergence is an industry segment within healthcare and research in life science that emphasizes the synergy between engineering/technology and computerized systems.
BICO’s Investor Relations contact details are listed, including phone and email for inquiries.
The page instructs users to report a suspected cybersecurity incident to BICO Security team to trigger immediate response actions and limit business impact.
The page instructs users to contact BICO’s Security Team to report cybersecurity incidents.
BICO offers expert consultations for research goals, product demos, and technical guidance.
BICO serves the world’s leading pharma and biotech companies with lab automation solutions that transform how labs operate and innovate.
View and download the Articles of Association for BICO AB (publ) (org. nr. 559050-5052).
BICO's Code of Conduct is based on human and labor rights, information protection, environment, health and safety, governance and management systems, product safety & business ethics.